Triple-negative breast cancer in African-American women: disparities versus biology

[1]  Huang Jun,et al.  Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype , 2014 .

[2]  J. Carpten,et al.  Abstract 2368: Differential gene expression in key oncolytic pathways between node-matched Caucasian-American, African-American and East African triple-negative breast cancer patients , 2014 .

[3]  S. Murphy,et al.  Imprinted Genes and the Environment: Links to the Toxic Metals Arsenic, Cadmium and Lead , 2014, Genes.

[4]  K. Servick.  Breast cancer. Breast cancer: a world of differences. , 2014, Science.

[5]  C. Shriver,et al.  Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer , 2014, BMC Cancer.

[6]  Jinfeng Zhang,et al.  Differentially Expressed Transcripts and Dysregulated Signaling Pathways and Networks in African American Breast Cancer , 2013, PloS one.

[7]  L. Harris,et al.  Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy , 2013, PloS one.

[8]  A. Neugut,et al.  Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series , 2013, Breast Cancer Research.

[9]  P. Marcom,et al.  Prevalence of BRCA Mutations Among Women with Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling Cohort , 2013, Annals of Surgical Oncology.

[10]  Jeffrey H Silber,et al.  Characteristics associated with differences in survival among black and white women with breast cancer. , 2013, JAMA.

[11]  D. Danforth.  Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors , 2013, Breast Cancer Research.

[12]  G. Mills,et al.  Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8. , 2013, Cancer research.

[13]  C. Loddenkemper,et al.  WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer , 2013, EMBO molecular medicine.

[14]  Lawal AbdulRazzaq Oluwagbemiga,et al.  Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? – a systematic review , 2012, SpringerPlus.

[15]  Yuet-Kin Leung,et al.  Environmental epigenetics and its implication on disease risk and health outcomes. , 2012, ILAR journal.

[16]  C. Rotimi,et al.  Genetic Susceptibility Loci for Subtypes of Breast Cancer in an African American Population , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[17]  A. Sood,et al.  Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer. , 2012, Human pathology.

[18]  P. Boyle,et al.  Triple-negative breast cancer: epidemiological considerations and recommendations. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  S. Murphy,et al.  Differentially Methylated Regions of Imprinted Genes in Prenatal, Perinatal and Postnatal Human Tissues , 2012, PloS one.

[20]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[21]  R. Rocha,et al.  Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers , 2012, Pathology.

[22]  K. Griffith,et al.  Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression , 2012, Breast Cancer Research and Treatment.

[23]  O. Olopade,et al.  Novel germline PALB2 truncating mutations in African American breast cancer patients , 2012, Cancer.

[24]  B. Deyarmin,et al.  Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women , 2012, Cancer.

[25]  Z. Werb,et al.  The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.

[26]  Yonghe Li,et al.  The wnt/β‐catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer , 2012, Journal of cellular biochemistry.

[27]  Päivi Heikkilä,et al.  Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[28]  Jane E. Carpenter,et al.  A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer , 2011, Nature Genetics.

[29]  L. Bernstein,et al.  Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Kevin W Eliceiri,et al.  Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2 , 2011, Nature Medicine.

[31]  Abena B. Redwood,et al.  A new pathway that regulates 53BP1 stability implicates Cathepsin L and vitamin D in DNA repair , 2011, EMBO Journal.

[32]  J. Palmer,et al.  Parity and Lactation in Relation to Estrogen Receptor Negative Breast Cancer in African American Women , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[33]  O. Bermudez,et al.  Beginning a discussion of nutrition and health disparities. , 2011, The American journal of clinical nutrition.

[34]  A. Ventura,et al.  Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer. , 2011, Cancer research.

[35]  K. Eliceiri,et al.  Aligned collagen is a prognostic signature for survival in human breast carcinoma. , 2011, The American journal of pathology.

[36]  Jorge S Reis-Filho,et al.  Triple-negative breast cancer. , 2010, The New England journal of medicine.

[37]  G. Hortobagyi,et al.  Higher parity and shorter breastfeeding duration , 2010, Cancer.

[38]  O. Olopade,et al.  Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population , 2010, Breast Cancer Research and Treatment.

[39]  J. Palmer,et al.  Polymorphisms in the TOX3/LOC643714 Locus and Risk of Breast Cancer in African-American Women , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[40]  L. Lambertini,et al.  Epigenetics in women's health care. , 2010, The Mount Sinai journal of medicine, New York.

[41]  L. Akslen,et al.  Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer , 2009, British Journal of Cancer.

[42]  C. Perou,et al.  Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Jeffrey M. Rosen,et al.  Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.

[44]  Dawn L Hershman,et al.  Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. , 2009, Journal of the National Cancer Institute.

[45]  D. Rose,et al.  The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. , 2009, Journal of women's health.

[46]  Christine B Ambrosone,et al.  Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors , 2009, Breast Cancer Research.

[47]  T. Lash,et al.  Triple-negative breast cancers are increased in black women regardless of age or body mass index , 2009, Breast Cancer Research.

[48]  R. Stephens,et al.  Differences in the Tumor Microenvironment between African-American and European-American Breast Cancer Patients , 2009, PloS one.

[49]  G. Hortobagyi,et al.  Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  H. Horlings,et al.  EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer , 2008, Breast Cancer Research.

[51]  G. Hortobagyi,et al.  Transcriptional profiles of triple receptor-negative breast cancer: Are Caucasian, Hispanic, and African-American women different? , 2008 .

[52]  Charlotte Kuperwasser,et al.  Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy , 2008, Breast Cancer Research.

[53]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[54]  A. Rosenberg,et al.  Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients , 2007, Cancer.

[55]  R. Theriault,et al.  Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center? , 2007, Breast Cancer Research and Treatment.

[56]  R. Cress,et al.  Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype , 2007, Cancer.

[57]  W. Woodward,et al.  African‐American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin‐based chemotherapy , 2006, Cancer.

[58]  D. Easton,et al.  Models of genetic susceptibility to breast cancer , 2006, Oncogene.

[59]  C. Perou,et al.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.

[60]  G. Colditz,et al.  Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  Zhao Chen,et al.  Ethnicity and breast cancer: factors influencing differences in incidence and outcome. , 2005, Journal of the National Cancer Institute.

[62]  L. Esserman,et al.  Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. , 2005, JAMA.

[63]  Ernie Hood,et al.  Dwelling Disparities: How Poor Housing Leads to Poor Health , 2005, Environmental health perspectives.

[64]  L. Newman,et al.  Breast cancer in sub‐Saharan Africa: How does it relate to breast cancer in African‐American women? , 2005, Cancer.

[65]  C. Rotimi,et al.  Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients , 2005, Journal of Medical Genetics.

[66]  D. Stahl,et al.  The Role of Syntrophic Associations in Sustaining Anaerobic Mineralization of Chlorinated Organic Compounds , 2004, Environmental health perspectives.

[67]  Yoshio Miki,et al.  Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage , 2004, Cancer science.

[68]  Debashis Ghosh,et al.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[69]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Cathy J Bradley,et al.  Race, socioeconomic status, and breast cancer treatment and survival. , 2002, Journal of the National Cancer Institute.

[71]  S. A. Black.  Diabetes, diversity, and disparity: what do we do with the evidence? , 2002, American journal of public health.

[72]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[73]  R. Millikan,et al.  Tumor characteristics in African American and white women , 2001, Breast Cancer Research and Treatment.

[74]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[75]  C. Adebamowo,et al.  Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer , 2000, Human Genetics.

[76]  C. Falkson,et al.  Absence of commonly recurring BRCA1 mutations in black South African women with breast cancer. , 2000, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[77]  Olufunmilayo I. Olopade,et al.  Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer , 2000, Human Genetics.

[78]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[79]  B. Dawson-Hughes,et al.  Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. , 1998, The American journal of clinical nutrition.

[80]  M. King,et al.  Population genetics of BRCA1 and BRCA2. , 1997, American journal of human genetics.

[81]  J Z Ayanian,et al.  The relation between health insurance coverage and clinical outcomes among women with breast cancer. , 1994, The New England journal of medicine.

[82]  M. King,et al.  Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.

[83]  W. McWhorter,et al.  Black/white differences in type of initial breast cancer treatment and implications for survival. , 1987, American journal of public health.

[84]  J. Adams,et al.  INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3 , 1982, The Lancet.

[85]  S. Murphy,et al.  Imprinted Genes and the Environment : Links to the Toxic Metals Arsenic , Cadmium , Lead and Mercury , 2014 .

[86]  P. Ang,et al.  Breast-cancer risk in families with mutations in PALB2. , 2014, The New England journal of medicine.

[87]  T. Walsh,et al.  Inherited mutations in breast cancer genes in African American breast cancer patients revealed by targeted genomic capture and next-generation sequencing. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[88]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[89]  M. Pierobon,et al.  Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis , 2012, Breast Cancer Research and Treatment.

[90]  J. Bellon.  African Ancestry and Higher Prevalence of Triple-Negative Breast Cancer: Findings From an International Study , 2011 .

[91]  R. Coates,et al.  Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA , 2008, Breast Cancer Research and Treatment.

[92]  C. Adebamowo,et al.  Evidence for an ancient BRCA1 mutation in breast cancer patients of yoruban ancestry , 2008, Familial Cancer.

[93]  Beth Newman,et al.  Comparative analysis of breast cancer risk factors among African-American women and White women. , 2005, American journal of epidemiology.

[94]  O. Olopade,et al.  Breast cancer genetics in African Americans , 2003, Cancer.